Clinical Trial Update: A Phase 1b Study of Gemcitabine and Nab-paclitaxel in Combination With IM156 in Patients With Advanced Pancreatic Cancer. [Phase 1]

View source ↗

Summary

Phase 1b trial evaluating the combination of gemcitabine, nab-paclitaxel, and IM156 in patients with advanced pancreatic cancer; the study is currently active b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Gemzar (gemcitabine)
• IM156 (IM156)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Pancreas Cancer | Phase 1 | Status: ACTIVE_NOT_RECRUITING